Moneycontrol PRO
LAMF
LAMF

Shares of smallcap pharma stock rise nearly 40% in 4 sessions; check key details

The rally comes ahead of the company’s dividend record date on September 16.
September 12, 2025 / 14:31 IST
Shares of smallcap pharma stock rises nearly 40% in 4 sessions.

Shares of smallcap pharmaceutical company Sigachi Industries have gained close to 40 percent in the last four sessions amid heavy trading volumes.

The stock rose 36.89 percent during this period and on Friday was trading 15.44 percent higher at Rs 43.52 apiece on the NSE.

The rally comes ahead of the company’s dividend record date on September 16. Sigachi has fixed the date for determining eligibility for dividend, the company said in a filing on September 4.

At its annual general meeting on September 1, the Hyderabad-based firm’s board recommended a dividend of 10 percent, or Rs 0.10 per equity share, for FY 2024-25.

In Friday’s trade, 2.56 crore shares of the company changed hands, generating a turnover of Rs 107.76 crore. On the NSE, volumes stood at 15.72 crore shares.

Sigachi Industries, part of the BSE SmallCap index, has a market capitalisation of Rs 1,656.48 crore, according to the BSE website.

- Disclaimer: The views and investment tips expressed by experts on Moneycontrol are their own and not those of the website or its management. Moneycontrol advises users to check with certified experts before taking any investment decisions.
Moneycontrol News
first published: Sep 12, 2025 02:31 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347